L
Letizia Santinelli
Researcher at Sapienza University of Rome
Publications - 39
Citations - 614
Letizia Santinelli is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 28 publications receiving 242 citations. Previous affiliations of Letizia Santinelli include Policlinico Umberto I.
Papers
More filters
Journal ArticleDOI
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review.
Gabriele d'Ettorre,Giancarlo Ceccarelli,Letizia Santinelli,Paolo Vassalini,Giuseppe Pietro Innocenti,Francesco Alessandri,Alexia E. Koukopoulos,Alessandro Russo,Gabriella d'Ettorre,Lorenzo Tarsitani +9 more
TL;DR: In this paper, a review aims to analyze the literature to discover which topics have been focused on and what the latest developments are in managing the occupational risk of post-traumatic stress symptoms (PTSS) in healthcare workers during the current COVID-19 pandemic.
Journal ArticleDOI
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review.
Fabio Infusino,Massimiliano Marazzato,Massimo Mancone,Francesco Fedele,Claudio Maria Mastroianni,Paolo Severino,Giancarlo Ceccarelli,Letizia Santinelli,Elena Cavarretta,Antonino G.M. Marullo,Fabio Miraldi,Roberto Carnevale,Cristina Nocella,Giuseppe Biondi-Zoccai,Cristiano Pagnini,Sonia Schiavon,Francesco Pugliese,Giacomo Frati,Gabriella d'Ettorre +18 more
TL;DR: There are no specific data available, and rigorous clinical trials should be conducted to confirm the putative benefits of diet supplementation, probiotics, and nutraceuticals in the current pandemic, but large scientific evidence supports the benefits that some bacterial and molecular products may exert on the immune response to respiratory viruses.
Journal ArticleDOI
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
Giancarlo Ceccarelli,Giancarlo Ceccarelli,Cristian Borrazzo,Cristian Borrazzo,Claudia Pinacchio,Letizia Santinelli,Giuseppe Pietro Innocenti,Eugenio Nelson Cavallari,Eugenio Nelson Cavallari,Luigi Celani,Luigi Celani,Massimiliano Marazzato,Francesco Alessandri,Franco Ruberto,Francesco Pugliese,Mario Venditti,Mario Venditti,Claudio Maria Mastroianni,Claudio Maria Mastroianni,Gabriella d'Ettorre,Gabriella d'Ettorre +20 more
TL;DR: In this article, the authors compared the effects of modulation of the microbial flora in patients with severe COVID-19 pneumonia with the best available therapy (BAT) vs. oral bacteriotherapy.
Journal ArticleDOI
Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection.
Ornella Spagnolello,Claudia Pinacchio,Letizia Santinelli,Paolo Vassalini,Giuseppe Pietro Innocenti,Gabriella De Girolamo,Gabriella De Girolamo,Silvia Fabris,Marta Giovanetti,Marta Giovanetti,Silvia Angeletti,Alessandro Russo,Alessandro Russo,Claudio Maria Mastroianni,Claudio Maria Mastroianni,Massimo Ciccozzi,Giancarlo Ceccarelli,Giancarlo Ceccarelli,Gabriella d'Ettorre,Gabriella d'Ettorre +19 more
TL;DR: Addressing intestinal dysbiosis with a probiotic supplement may be a sensible option to be evaluated, in addition to current best available medical treatments, for preventing and treating COVID-19 pneumonia.
Journal ArticleDOI
Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS.
Giancarlo Ceccarelli,Maura Statzu,Letizia Santinelli,Claudia Pinacchio,Camilla Bitossi,Eugenio Nelson Cavallari,Vincenzo Vullo,Carolina Scagnolari,GabrieIla d'Ettorre +8 more
TL;DR: Despite the growing use of probiotic therapy, mechanisms by which oral bacteria intake exhibits its effects are strain-related and disease-specific, hence clinicians need to take these two factors into consideration when suggesting probiotic supplementation to HIV-infected patients.